NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript

NuPathe (PATH)

Q2 2012 Earnings Call

August 14, 2012 8:30 am ET

Executives

John Woolford - Principal

Armando Anido - Chief Executive Officer and Director

Keith A. Goldan - Chief Financial Officer, Principal Accounting Officer and Vice President

Terri B. Sebree - Co-Founder and President

Gerald W. McLaughlin - Vice President of Commercial Operations

Analysts

Michael W. Schmidt - Leerink Swann LLC, Research Division

William Tanner - Lazard Capital Markets LLC, Research Division

Elliot Wilbur - Needham & Company, LLC, Research Division

Annabel Samimy - Stifel, Nicolaus & Co., Inc., Research Division

Presentation

Operator

» Sangamo BioSciences' CEO Presents at the 2012 Wedbush PacGrow Lifesciences Management Access Conference (Transcript)
» Emergent BioSolutions' Management Presents at Wedbush 2012 Life Sciences Management Access Conference Call (Transcript)
» NPS Pharmaceuticals' CEO Presents at Canaccord Genuity 32nd Annual Growth Conference (Transcript)

Good day, ladies and gentlemen, and welcome to the NuPathe's Second Quarter 2012 Earnings Conference Call. As a reminder, today's call is being recorded. Now for opening remarks and introductions, I'll turn the call over to Mr. John Woolford. Mr. Woolford, please go ahead.

John Woolford

Thank you, operator, and good morning, everyone. With me on this morning's call are Armando Anido, Chief Executive Officer; and Keith Goldan, Vice President and Chief Financial Officer. Terri Sebree, President; and Jerry McLaughlin, Vice President of Commercial Operations, will also be joining us for the Q&A portion of the call.

We announced second quarter 2012 financial results today before the open of the U.S. financial markets. For those of you who may not have seen the release, it is available on our website at www.nupathe.com, in the Investor Relations section.

The format of today's call is as follows: Armando will begin with an overview of recent corporate highlights. Keith will then provide a summary of our financial results for the quarter, and Armando will end the prepared remarks with a brief closing, followed by a Q&A session.

1 2 3 Next › Last »